Peng 2017.

Methods	Study design: Randomised clinical trial Study duration: December 2013 to June 26 Duration of follow‐up: 1 month Setting: Hospital
Participants	Age (mean ± SD, range): 65.5 ± 3.5 years, 21‐80 years Male (n/total): 34/64
Interventions	TACE + MWA group (n = 32): TACE: Chemotherapeutic drugs: cisplatin 30‐60 mg, mitomycin 4‐10 mg, and adriamycin 10‐50 mg. MWA: DSA/CT‐guided MWA. Frequency of 40‐60 Hz, 6‐10 minutes per MWA session TACE group (n = 32): Chemotherapeutic drugs: cisplatin 30‐60 mg, mitomycin 4‐10 mg, and adriamycin 10‐50 mg
Outcomes	Tumour response, classified as complete response, partial response, stable disease, and progression, measured at 4 weeks after treatment Adverse events Liver function 2‐year survival rate and metastasis rate
Notes	Country of study: China Source of funding: Maoming Medical Project There was insufficient information available to satisfactorily determine the method of randomisation and the study data could not be verified. We have attempted to contact the study authors for more information, but so far, we have not been successful in doing this.